Correlation Between Vitrolife and CellaVision

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vitrolife and CellaVision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and CellaVision into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and CellaVision AB, you can compare the effects of market volatilities on Vitrolife and CellaVision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of CellaVision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and CellaVision.

Diversification Opportunities for Vitrolife and CellaVision

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Vitrolife and CellaVision is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and CellaVision AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CellaVision AB and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with CellaVision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CellaVision AB has no effect on the direction of Vitrolife i.e., Vitrolife and CellaVision go up and down completely randomly.

Pair Corralation between Vitrolife and CellaVision

Assuming the 90 days trading horizon Vitrolife AB is expected to generate 0.92 times more return on investment than CellaVision. However, Vitrolife AB is 1.09 times less risky than CellaVision. It trades about 0.01 of its potential returns per unit of risk. CellaVision AB is currently generating about 0.0 per unit of risk. If you would invest  15,269  in Vitrolife AB on April 24, 2025 and sell it today you would lose (789.00) from holding Vitrolife AB or give up 5.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vitrolife AB  vs.  CellaVision AB

 Performance 
       Timeline  
Vitrolife AB 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vitrolife AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vitrolife is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
CellaVision AB 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CellaVision AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CellaVision may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Vitrolife and CellaVision Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vitrolife and CellaVision

The main advantage of trading using opposite Vitrolife and CellaVision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, CellaVision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CellaVision will offset losses from the drop in CellaVision's long position.
The idea behind Vitrolife AB and CellaVision AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data